Propensity score-based analysis of 30-day survival in cardiogenic shock patients supported with different microaxial left ventricular assist devices
Gaik Nersesian*1,4, Evgenij V Potapov*1,4, Vivian Nelki2, Julia Stein1, Christoph Starck1,4, Volkmar Falk1,3,4,6, Felix Schoenrath1,4, Florian Krackhardt2, Carsten Tschöpe*2,4,5, Frank Spillmann*2,5
1 Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany
2 Department of Internal Medicine and Cardiology, Charité-Universitätsmedizin Berlin, Germany
3 Department of Cardiothoracic Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
4 DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany;
5 Berlin Institute of Health (BIH) Berlin-Brandenburg Center for Regenerative Therapy (BCRT), Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany
6 Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland
* Authors contributed equally to the study